BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jaeger WC, Armstrong SP, Hill SJ, Pfleger KD. Biophysical Detection of Diversity and Bias in GPCR Function. Front Endocrinol (Lausanne) 2014;5:26. [PMID: 24634666 DOI: 10.3389/fendo.2014.00026] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Ayoub MA, Zhang Y, Kelly RS, See HB, Johnstone EK, McCall EA, Williams JH, Kelly DJ, Pfleger KD. Functional interaction between angiotensin II receptor type 1 and chemokine (C-C motif) receptor 2 with implications for chronic kidney disease. PLoS One 2015;10:e0119803. [PMID: 25807547 DOI: 10.1371/journal.pone.0119803] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 4.7] [Reference Citation Analysis]
2 Johnstone EK, Pfleger KD. Bioluminescence Resonance Energy Transfer Approaches to Discover Bias in GPCR Signaling. Methods Mol Biol 2015;1335:191-204. [PMID: 26260602 DOI: 10.1007/978-1-4939-2914-6_13] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
3 Dale NC, Hoyer D, Jacobson LH, Pfleger KDG, Johnstone EKM. Orexin Signaling: A Complex, Multifaceted Process. Front Cell Neurosci 2022;16:812359. [DOI: 10.3389/fncel.2022.812359] [Reference Citation Analysis]
4 Soave M, Cseke G, Hutchings CJ, Brown AJH, Woolard J, Hill SJ. A monoclonal antibody raised against a thermo-stabilised β1-adrenoceptor interacts with extracellular loop 2 and acts as a negative allosteric modulator of a sub-set of β1-adrenoceptors expressed in stable cell lines. Biochem Pharmacol 2018;147:38-54. [PMID: 29102678 DOI: 10.1016/j.bcp.2017.10.015] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
5 Ayoub MA. Resonance Energy Transfer-Based Approaches to Study GPCRs. Methods Cell Biol 2016;132:255-92. [PMID: 26928548 DOI: 10.1016/bs.mcb.2015.10.008] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
6 Gomes I, Sierra S, Devi LA. Detection of Receptor Heteromerization Using In Situ Proximity Ligation Assay. Curr Protoc Pharmacol 2016;75:2.16.1-2.16.31. [PMID: 27960030 DOI: 10.1002/cpph.15] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 4.3] [Reference Citation Analysis]
7 Mallipeddi S, Janero DR, Zvonok N, Makriyannis A. Functional selectivity at G-protein coupled receptors: Advancing cannabinoid receptors as drug targets. Biochem Pharmacol 2017;128:1-11. [PMID: 27890725 DOI: 10.1016/j.bcp.2016.11.014] [Cited by in Crossref: 49] [Cited by in F6Publishing: 43] [Article Influence: 8.2] [Reference Citation Analysis]
8 Kong X, Li ZX, Gao YQ, Liu FH, Chen ZZ, Tian HG, Liu TX, Xu YY, Kang ZW. Genome-Wide Identification of Neuropeptides and Their Receptors in an Aphid Endoparasitoid Wasp, Aphidius gifuensi. Insects 2021;12:745. [PMID: 34442310 DOI: 10.3390/insects12080745] [Reference Citation Analysis]
9 Cheng X, Jiang H. Allostery in Drug Development. In: Zhang J, Nussinov R, editors. Protein Allostery in Drug Discovery. Singapore: Springer; 2019. pp. 1-23. [DOI: 10.1007/978-981-13-8719-7_1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
10 Al-Sabah S, Adi L, Bünemann M, Krasel C. The Effect of Cell Surface Expression and Linker Sequence on the Recruitment of Arrestin to the GIP Receptor. Front Pharmacol 2020;11:1271. [PMID: 32903502 DOI: 10.3389/fphar.2020.01271] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
11 Johnstone EKM, Pfleger KDG. Profiling novel pharmacology of receptor complexes using Receptor-HIT. Biochem Soc Trans 2021;49:1555-65. [PMID: 34436548 DOI: 10.1042/BST20201110] [Reference Citation Analysis]
12 Kadam P, McAllister R, Urbach JS, Sandberg K, Mueller SC. Live Cell Imaging and 3D Analysis of Angiotensin Receptor Type 1a Trafficking in Transfected Human Embryonic Kidney Cells Using Confocal Microscopy. J Vis Exp 2017. [PMID: 28447987 DOI: 10.3791/55177] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
13 Stoddart LA, Kilpatrick LE, Hill SJ. NanoBRET Approaches to Study Ligand Binding to GPCRs and RTKs. Trends Pharmacol Sci 2018;39:136-47. [PMID: 29132917 DOI: 10.1016/j.tips.2017.10.006] [Cited by in Crossref: 45] [Cited by in F6Publishing: 43] [Article Influence: 9.0] [Reference Citation Analysis]
14 Dale NC, Johnstone EKM, White CW, Pfleger KDG. NanoBRET: The Bright Future of Proximity-Based Assays. Front Bioeng Biotechnol 2019;7:56. [PMID: 30972335 DOI: 10.3389/fbioe.2019.00056] [Cited by in Crossref: 33] [Cited by in F6Publishing: 27] [Article Influence: 11.0] [Reference Citation Analysis]
15 Kassel S, Schwed JS, Stark H. Dopamine D3 receptor agonists as pharmacological tools. Eur Neuropsychopharmacol 2015;25:1480-99. [PMID: 25498414 DOI: 10.1016/j.euroneuro.2014.11.005] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
16 Sebastianutto I, Goyet E, Andreoli L, Font-Ingles J, Moreno-Delgado D, Bouquier N, Jahannault-Talignani C, Moutin E, Di Menna L, Maslava N, Pin JP, Fagni L, Nicoletti F, Ango F, Cenci MA, Perroy J. D1-mGlu5 heteromers mediate noncanonical dopamine signaling in Parkinson's disease. J Clin Invest 2020;130:1168-84. [PMID: 32039920 DOI: 10.1172/JCI126361] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
17 Pickering RJ, Tikellis C, Rosado CJ, Tsorotes D, Dimitropoulos A, Smith M, Huet O, Seeber RM, Abhayawardana R, Johnstone EK, Golledge J, Wang Y, Jandeleit-Dahm KA, Cooper ME, Pfleger KD, Thomas MC. Transactivation of RAGE mediates angiotensin-induced inflammation and atherogenesis. J Clin Invest 2019;129:406-21. [PMID: 30530993 DOI: 10.1172/JCI99987] [Cited by in Crossref: 34] [Cited by in F6Publishing: 18] [Article Influence: 8.5] [Reference Citation Analysis]
18 Gomes I, Ayoub MA, Fujita W, Jaeger WC, Pfleger KD, Devi LA. G Protein-Coupled Receptor Heteromers. Annu Rev Pharmacol Toxicol 2016;56:403-25. [PMID: 26514203 DOI: 10.1146/annurev-pharmtox-011613-135952] [Cited by in Crossref: 168] [Cited by in F6Publishing: 140] [Article Influence: 24.0] [Reference Citation Analysis]
19 Johnstone EKM, See HB, Abhayawardana RS, Song A, Rosengren KJ, Hill SJ, Pfleger KDG. Investigation of Receptor Heteromers Using NanoBRET Ligand Binding. Int J Mol Sci 2021;22:1082. [PMID: 33499147 DOI: 10.3390/ijms22031082] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
20 Kilpatrick LE, Alcobia DC, White CW, Peach CJ, Glenn JR, Zimmerman K, Kondrashov A, Pfleger KDG, Ohana RF, Robers MB, Wood KV, Sloan EK, Woolard J, Hill SJ. Complex Formation between VEGFR2 and the β2-Adrenoceptor. Cell Chem Biol 2019;26:830-841.e9. [PMID: 30956148 DOI: 10.1016/j.chembiol.2019.02.014] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
21 Stoddart LA, Johnstone EKM, Wheal AJ, Goulding J, Robers MB, Machleidt T, Wood KV, Hill SJ, Pfleger KDG. Application of BRET to monitor ligand binding to GPCRs. Nat Methods 2015;12:661-3. [PMID: 26030448 DOI: 10.1038/nmeth.3398] [Cited by in Crossref: 145] [Cited by in F6Publishing: 137] [Article Influence: 20.7] [Reference Citation Analysis]
22 Saier MH Jr, Reddy VS, Tsu BV, Ahmed MS, Li C, Moreno-Hagelsieb G. The Transporter Classification Database (TCDB): recent advances. Nucleic Acids Res 2016;44:D372-9. [PMID: 26546518 DOI: 10.1093/nar/gkv1103] [Cited by in Crossref: 428] [Cited by in F6Publishing: 350] [Article Influence: 61.1] [Reference Citation Analysis]